Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas-MedSci.cn

Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas

Liu, ZY; Yao, WT; Zhao, Y; Liu, OF; Zhang, P; Ge, H

Ge, H (corresponding author), Henan Canc Hosp, Zhengzhou, Henan, Peoples R China.; Ge, H (corresponding author), Zhengzhou Univ, Dept Radiat Oncol, Affiliated Canc Hosp, Zhengzhou, Henan, Peoples R China.

Abstract

Purpose: Anlotinib is a novel tyrosine kinase inhibitor with promising anti-tumor activity in patients with advanced soft tissue sarcomas (STS) in Chi......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas

科室

工具

服务